Theravance Bio: 1Q Earnings Snapshot

May 6, 2020 GMT

GEORGE TOWN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Wednesday reported a loss of $83.1 million in its first quarter.

The George Town, Cayman Islands-based company said it had a loss of $1.40 per share. Losses, adjusted to extinguish debt, were $1.14 per share.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.06 per share.

The biopharmaceutical company posted revenue of $19.9 million in the period, exceeding Street forecasts. Four analysts surveyed by Zacks expected $18 million.


Theravance Bio shares have climbed nearly 9% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $28.13, an increase of 12% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TBPH at https://www.zacks.com/ap/TBPH